← Leaderboards
Leonidas Bantis
University Of Kansas Medical Center
$125,938
Attributed
$377,815
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $188.9K · FY2020–21$200K$150K$100K$50K$0
'20
'21
Funding mix
By agency
NIH$377,815 · 1
By mechanism
P20$377,815 · 1
Top collaborators
- Steven A. Soper2 shared
- Alan S Yu2 shared
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Jeffrey Murray Burns$33,960,578
- Russell H Swerdlow$17,139,092
- Severin O Gudima$5,431,875
- Eric Dennis Vidoni$8,219,970
- Heather M. Wilkins$3,547,191
Others in their field
Other Emerging Leaders on “Antigen-Antibody Complex”
- Taia Wang · Stanford University$6,387,610
- Michiko Oyoshi · Boston Children'S Hospital$4,595,561
- Aaron Gregory Schmidt · Boston Children'S Hospital$4,146,349
- Vivek Thumbigere-Math · University Of Maryland Baltimore$3,340,009
- Patrick S Mitchell · University Of Washington$2,475,525
- David Noel O'Dwyer · University Of Michigan At Ann Arbor$2,413,266
Research focus
Antigen-Antibody ComplexAntigensApoptosisAreaAsthmaticAutoantibodiesBaseBehaviorBiological MarkersBiomarker DiscoveryBiomarker EvaluationBladder CarcinomaBlood-Based BiomarkerBreastBronchoalveolar Lavage FluidCancer CellCancer PatientCancer RiskCdkn2a GeneClinical Decision-MakingClinically RelevantCostDecision MakingAdult Respiratory Distress Syndrome
Grant awards (2)
Discovery, Evaluation and Clinical Decision Making Based on Non-Monotone Biomarkers for the Early Detection of Disease$188,906
P20 · FY2021 · GM · contact PI
Discovery, Evaluation and Clinical Decision Making Based on Non-Monotone Biomarkers for the Early Detection of Disease$188,909
P20 · FY2020 · GM · contact PI